Accelerating Drug Discovery with Reliable ADME-DMPK Insights
Confident decisions start with confident data. Syngene’s integrated DMPK services help you uncover drug-like properties early, predict clinical behavior with clarity, and reduce the risk of late-stage failures.
From in vitro ADME to in vivo PK, bioanalysis, and modelling, we deliver high-quality, reproducible insights with speed, accuracy, and complete transparency.
Trusted to deliver critical programs for global innovators
15+
Years of
Experience
240+
Assay Types
to choose
600+
Assays to
Order
In Vitro ADME
Identify liabilities early. Strengthen your hit-to-lead decisions.
A comprehensive suite of ADME assays designed to reveal drug-like properties, highlight risks, and refine your candidate selection strategy.
In Vivo Pharmacokinetics
Understand how your compound behaves dose, exposure, clearance, and beyond.
Our in vivo PK studies are tailored to your molecule, therapeutic area, and development objectives, providing the clarity needed to guide dosing and candidate advancement.
Modelling & Simulation
Turn preclinical data into predictive clinical insight.
Our modelling and simulation capabilities help accelerate decision-making by forecasting exposure, optimizing dose selection, and predicting human PK outcomes.
Biologics & New Modalities
Purpose-built DMPK solutions for complex therapeutic formats.
We bring extensive experience in large molecules and emerging modalities, supported by advanced bioanalytical workflows and custom assay development
Driving Innovation, Delivering Results.
30+ Years of Discovery Expertise
Supporting 100+ global clients
95%+ TAT Adherence
Ensuring rapid data delivery in as little as 10 days
Transparency & Seamless Experience
Real time study visibility through the SynE MAP platform with intuitive, data rich dashboards
Data Continuity & IND Readiness
Integrated biology, chemistry, PK, and bioanalysis aligned under one quality system.
Predictive Readouts
Make go/no-go decisions earlier using connected in vitro, in vivo, and modelling capabilities.
Modality Agnostic
Expertise across small molecules, biologics, PROTACs, ADCs, peptides, and oligonucleotides.
SYNe-MAP: Your Digital DMPK Hub Fast. Transparent. Connected.
SYNe-MAP, Syngene’s proprietary digital platform, simplifies and accelerates every stage of your DMPK workflow, from ordering to data delivery.
• Seamless ordering of 240+ assay types
• Real-time monitoring of experiment progress
• Reduced dependency with role-based access
• Single source of truth for all study data
• Graphical analytics for informed decision-making
• Complete workflow visibility: compound receipt → experiments → QC → final report
Proven Impact Across Discovery and Preclinical Development
Explore how global innovators accelerated timelines, strengthened candidate selection, and advanced compounds with confidence using Syngene’s DMPK capabilities.
Ready to Accelerate Your Drug Discovery Program?
From early screening to IND-ready packages, Syngene combines scientific depth, digital transparency, and scale to deliver the insights you need—fast, accurate, and development-ready.
Ready to fast-track your Drug Discovery?
From in vitro ADME to in vivo PK, bioanalysis, and modelling, Syngene delivers the expertise, technology, and scale. Move your project forward faster and with confidence.